Herpes zoster virus of shingles
About us We are a science-led global healthcare company with a special purpose: to help people do more, feel better, live longer.
Read morePress releases
- GSK completes acquisition of TESARO, an oncology focused biopharmaceutical company
- GSK announces succession plan to appoint new Chairman
- Two positive phase III studies of tafenoquine for the radical cure of Plasmodium vivax malaria published in The New England Journal of Medicine
Tweets from GSK
-
GSK @GSK
As one of the few companies committed to researching treatments and vaccines for #HIV, #TB and #malaria we’re proud to be talking with @PCuresResearch @DNDi @UNITAID @WHO and others today about investment in R&D for neglected diseases #GFINDER #globalhealth #GlobalGoals
about 2 hours ago -
GSK @GSK
#NEWS Today we successfully completed the acquisition of TESARO Inc, an oncology-focused company. This significantly strengthens our pharmaceutical business, and accelerates the build of our pipeline and commercial capability in #oncology: gsk.to/2FHAflp
about 22 hours ago
-
GSK @GSK
We’re proud to be a 2019 #StonewallTop100 inclusive employer and delighted that our employee network group for LGBT+ employees and allies, Spectrum, has been named the best in the UK. Congratulations to all our Spectrum members. #ComeOutForLGBT twitter.com/stonewalluk/st…
about 2 days ago
